×
About 3,118 results

ALLMedicine™ Growth Hormone Deficiency Center

Research & Reviews  972 results

Long-term pegylated growth hormone for children with growth hormone deficiency: a large...
https://doi.org/10.1210/clinem/dgad039
The Journal of Clinical Endocrinology and Metabolism; Hou L, Huang K et. al.

Jan 21st, 2023 - The evidence of long-term polyethylene glycol recombinant human growth hormone (PEG-rhGH) in pediatric growth hormone deficiency (GHD) is limited. This study aimed to examine the effectiveness and safety of long-term PEG-rhGH in children with GHD ...

Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
https://clinicaltrials.gov/ct2/show/NCT04244123

Jan 18th, 2023 - Background: Recombinant human growth hormone (GH) is used in the treatment of short stature due to growth hormone deficiency, Turner syndrome, Prader Willi syndrome, small for gestational age with failure of catch up growth, chronic renal failure ...

A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT03344458

Jan 12th, 2023 - A multicenter, phase 3, long-term extension trial of TransCon hGH administered once-weekly in children with growth hormone deficiency (GHD) who previously participated in a phase 3 TransCon hGH trial. Approximately 300 children (males and females)...

Growth hormone deficiency in a case of septo-optic-dysplasia due to SOX2 mutation: shou...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806035
BMJ Case Reports; Gasco V, Matarazzo P et. al.

Dec 30th, 2022 - Gene mutations encoding transcription factors, including SOX2, have been associated with growth hormone deficiency (GHD) and abnormal pituitary development. Guidelines on GHD management in the transition period state that patients with genetic-bas...

Approach to a case with an unusual cause of hypopituitarism.
https://doi.org/10.1210/clinem/dgac747
The Journal of Clinical Endocrinology and Metabolism; Das L, Dutta P

Dec 28th, 2022 - Hypopituitarism refers to insufficiency of one or more hormones of the pituitary and can be due to myriad causes. The clinical and radiological spectrum of the condition is heterogeneous, based on the age, gender, clinical setting and/or other pas...

see more →

Guidelines  1 results

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pr...
https://doi.org/10.1227/NEU.0000000000001387
Neurosurgery Fleseriu M, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present with hypopituitarism and/or hyperprolactinemia. To review the existing literature as it pertains to preoperative endocrine assessment in the work...

see more →

Drugs  14 results see all →

Clinicaltrials.gov  166 results

Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
https://clinicaltrials.gov/ct2/show/NCT04244123

Jan 18th, 2023 - Background: Recombinant human growth hormone (GH) is used in the treatment of short stature due to growth hormone deficiency, Turner syndrome, Prader Willi syndrome, small for gestational age with failure of catch up growth, chronic renal failure ...

A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT03344458

Jan 12th, 2023 - A multicenter, phase 3, long-term extension trial of TransCon hGH administered once-weekly in children with growth hormone deficiency (GHD) who previously participated in a phase 3 TransCon hGH trial. Approximately 300 children (males and females)...

Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children
https://clinicaltrials.gov/ct2/show/NCT04513171

Dec 23rd, 2022 - This multicenter, randomized, open-labeled, positive controlled study is divided into two stages. The first one is aimed to exploit the optimal dose of Y-shape pegylated somatropin, while the second one is aimed to confirm the efficacy and safety ...

Growth Hormone Deficiency in Mild Traumatic Brain Injury
https://clinicaltrials.gov/ct2/show/NCT05660356

Dec 21st, 2022 - Annually, over 250,000 Canadians and over 40 million individuals worldwide will suffer an uncomplicated concussion (head injury with no intracranial abnormalities seen on imaging). Most individuals will recover within weeks of injury but over 30% ...

Genetic Causes of Growth Disorders
https://clinicaltrials.gov/ct2/show/NCT02311322

Dec 20th, 2022 - Children often present to pediatricians and pediatric endocrinologists because of abnormal body growth, including both childhood growth failure and, less commonly, overgrowth. Sometimes the cause is evident, for example, growth hormone deficiency ...

see more →

News  89 results

Second Biosimilar Insulin OK'd; Diabetes Risk After COVID; Omnipod DASH Recall
https://www.medpagetoday.com/endocrinology/generalendocrinology/101867

Nov 22nd, 2022 - The FDA approved the second interchangeable biosimilar insulin product, Eli Lilly's insulin glargine-aglr (Rezvoglar), for pediatric and adult patients with diabetes, the agency announced. Patients with diabetes and chronic kidney disease should b...

Diabetes Overtreated in Nursing Homes; Happy IVF Kids; Verapamil for Type 1 Diabetes
https://www.medpagetoday.com/endocrinology/generalendocrinology/97832

Mar 23rd, 2022 - In a study of 7,422 nursing home residents with type 2 diabetes, 17% met criteria for glycemic overtreatment and another 23% met criteria for potential overtreatment. (Journal of the American Geriatrics Society) Aeterna Zentaris announced some del...

More Positive Imcivree Data; ICER Reviews Tirzepatide; SGLT2 Inhibitors for Syncope?
https://www.medpagetoday.com/endocrinology/generalendocrinology/97279

Feb 20th, 2022 - Interim data from a long-term extension study of setmelanotide (Imcivree) for pediatric and adult patients with Bardet-Biedl Syndrome found an average BMI reduction of 14.3% from baseline and a 14.9% drop in body weight, Rhythm Pharmaceuticals ann...

Infectious and Back at Work; FDA May Limit Some Monoclonals; 'Done With COVID'?
https://www.medpagetoday.com/infectiousdisease/covid19/96821

Jan 24th, 2022 - Note that some links may require registration or subscription. Strained hospitals are calling potentially infectious healthcare workers back to their posts, citing the CDC's latest guidance. (Washington Post) NIAID Director Anthony Fauci, MD, said...

FDA Approves First Once-Weekly Growth Hormone for Children
https://www.medscape.com/viewarticle/958043

Sep 2nd, 2021 - The US Food and Drug Administration (FDA) has approved lonapegsomatropin (Skytrofa, Ascendis Pharma), the first weekly subcutaneous injectable growth hormone for children with growth hormone deficiency (GHD). The approval was based on the findings...

see more →

Patient Education  5 results see all →